Videos

Fiona C. Baker, PhD, emphasizes the importance of patient-reported outcomes in assessing elinzanetant’s overall benefit, including insights on symptom recurrence and quality-of-life improvements.

Laura Jelliffe-Pawlowski, PhD, MS, explains how the PTB-ARIx tool leverages modifiable clinical factors to strengthen patient-provider communication.

In phase 2 trials, cendifensine significantly reduced the frequency and severity of menopausal hot flashes and may offer broader symptom relief benefits.

David Lissauer, PhD, discusses how the APT-Sepsis program delivered a sustained 32% reduction in severe maternal infection outcomes

Camille Powe, MD, discusses how discontinuing GLP-1 receptor agonists before or during pregnancy may increase gestational weight gain and metabolic risks.

Discussion covers hepatic enzyme monitoring, oncologic safety considerations, and real-world precautions for NK antagonist use.

The panel underscores how quick onset of benefit improves adherence and patient satisfaction in clinical practice.

Fiona C. Baker, PhD, reviews NIRVANA’s findings showing early onset of relief for both VMS and sleep disturbances, supported by patient-reported improvements in sleep quality, duration, and nighttime awakenings.

Fiona C. Baker, PhD, outlines the NIRVANA study’s design and goals, noting its focus on evaluating elinzanetant’s impact on vasomotor symptoms and sleep-related outcomes.

Ayesha Dholakia, MD, highlights rising pregnancy-related homicides, driven largely by firearms.

Data shows widening disparities in cesarean births among Black birthing people and indicates a need for patient-centered care.

Embryologist shortages and emerging AI technologies are transforming IVF laboratories, driving the need for integrated systems and standardized workflows.

Emerging AI tools are improving efficiency and precision in IVF labs, but high costs and training limitations still prevent them from replacing manual expertise.

Sleep specialist Carleara Weiss, MD, PhD, MSH, RN, outlines the hormonal, physiological, and educational factors affecting sleep in menopausal women

FemBloc, a transcervical, incision-free method of permanent birth control, is advancing through its pivotal trial after strong early safety data.

Review of OASIS-1 through OASIS-4 trial results demonstrating consistent improvements in VMS frequency, severity, and sleep quality.

The experts examine the dual NK3/NK1 mechanism of elinzanetant and its broader potential to address mood and sleep disturbances.

New research shows that a single prophylactic antibiotic dose lowers clinically relevant wound complications after second-degree tears or episiotomy.

A study found that self-administered clinical hypnosis significantly reduced hot flashes and improved sleep.

Michael Warren, MD, MPH, FAAP, outlines how expanding maternity care deserts and rising chronic disease rates are driving poor maternal outcome.

Sarah M. Crafton, MD, discusses how a new investigational robotic platform is expanding minimally invasive options and improving outcomes for patients.

Research found only modest neonatal outcome differences between general and neuraxial anesthesia during cesarean delivery.

Michael Warren, MD, MPH, FAAP, explains the nation’s stagnant preterm birth rate and widening disparities highlighted in the 2025 report.

Deborah Anderson, PhD, highlights the need for improved contraception access, education, and research support worldwide.

Discussion highlights fezolinetant’s rapid-onset efficacy, favorable tolerability, and safety findings as the first NK3 antagonist approved for VMS.

The panel reviews the role of NK1 and NK3 receptors in thermoregulation and symptom genesis, setting the stage for targeted therapy.

Jessica Golbus, MD, discusses the benefits of cardiac rehabilitation and innovative solutions to improve access and engagement.

Jun Wang, PhD, and Rajesh Miranda, PhD, outline why prevention alone is insufficient and emphasize the need for early diagnosis for children affected by prenatal alcohol exposure.